Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase assembly factor 4 homolog (COA4) is an accessory mitochondrial protein critical for the assembly of cytochrome c oxidase (Complex IV), the terminal enzyme in the electron transport chain. COA4 is required for correct biogenesis of Complex IV and thereby for efficient mitochondrial respiration and ATP production. Mutations or deficiencies in COA4 disrupt oxidative phosphorylation, leading to mitochondrial disorders including cardio- and encephalomyopathies. COA4 functions as part of several macromolecular assemblies with other metallochaperones and twin CX9C proteins to coordinate metal center incorporation during cytochrome c oxidase biogenesis.
Not applicable. COA4 is not a therapeutic target for currently available drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase assembly factor 4 homolog (COA4).